Metabolic Diversity of Progressive Kidney Disease in 325 Patients with Type 1 Diabetes (the FinnDiane Study)
Ville‐Petteri Mäkinen(Helsinki University Hospital), Per‐Henrik Groop(University of Helsinki), Tuulia Tynkkynen(University of Eastern Finland), Lena M. Thorn(University of Helsinki), Kimmo Kaski(Aalto University), Reino Laatikainen(University of Eastern Finland), Mika Ala‐Korpela(University of Oulu), Antti J. Kangas(University of Oulu), Pasi Soininen(University of Eastern Finland), Tomi Peltola(Helsinki Institute for Information Technology), Carol Forsblom(University of Helsinki)
Cited by 73
Related Papers
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals
|Nature Metabolism|2020|775
The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
|Diabetes|2009|641
Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney Disease
|Journal of the American Society of Nephrology|2013|578
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
|Diabetes|1999|509
Metabolic Syndrome in Type 1 Diabetes
|Diabetes Care|2005|428